Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases

被引:43
作者
Dupre, Aurelien [1 ,2 ]
Malik, Hassan Z. [1 ]
Jones, Robert P. [1 ,3 ]
Diaz-Nieto, Rafael [1 ]
Fenwick, Stephen W. [1 ]
Poston, Graeme J. [1 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Liverpool Hepatobiliary Ctr, Longmoor Lane, Liverpool L9 7AL, Merseyside, England
[2] Ctr Leon Berard, Dept Surg Oncol, F-69008 Lyon, France
[3] Univ Liverpool, Inst Translat Med, Sch Canc Studies, Liverpool L69 3GA, Merseyside, England
来源
EJSO | 2018年 / 44卷 / 01期
关键词
Colorectal cancer; Liver metastases; Hepatectomy; Embryonic; Origin; Primary tumour; 2; SIDES; CANCER; RESECTION; SURVIVAL; HEPATECTOMY; METAANALYSIS; RECURRENCE; FEATURES; DISTAL;
D O I
10.1016/j.ejso.2017.10.218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The prognosis of patients undergoing liver resection for colorectal liver metastases (CLM) seems to be altered when the primary tumour is right-sided. However, data are lacking and conflicting. We aimed to evaluate the influence of the primary tumour location on oncologic outcomes following such surgery. Methods: We retrospectively analysed prospectively collected data from 376 consecutive patients who underwent liver surgery for CLM between June 2010 and August 2015. We compared the outcomes of patients with right colon tumours and those with left colorectal tumours. The splenic flexure was used as the cut-off point to determine the anatomic primary site. Results: Among the 364 patients eligible, 74 (20.3%) had a right-sided primary tumour. These patients were older, had a poorer American Society of Anaesthesiologists status and had fewer node-positive primary tumours. The CLM characteristics were similar between both groups. Median PFS was not significantly different between the two groups at 9.9 months, as well as the pattern of recurrence. Median OS was shorter for patients with right-sided primary tumour (34.6 versus 45.3 months, p = 0.035). Similar results were observed when patients with rectal tumour were excluded from analysis (34.6 vs. 47.5 months, p = 0.007). Primary tumour site was an independent prognosis factor in multivariate analysis. Conclusion: Right-sided location of the primary tumour is associated with worse OS after surgery for CLM, but seems to have no influence on PFS, and on the pattern of recurrence. (C) 2017 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 50 条
  • [21] Prognostic impact of K-RAS mutational status and primary tumor location in patients undergoing resection for colorectal cancer liver metastases: an update
    O'Connor, Juan M.
    Sanchez Loria, Fernando
    Ardiles, Victoria
    Grondona, Jorge
    Sanchez, Pablo
    Andriani, Oscar
    Fauda, Martin
    Brancato, Fernando
    Huertas, Eduardo
    Alvarez, Fernando
    de Santibanes, Eduardo
    FUTURE ONCOLOGY, 2019, 15 (27) : 3149 - 3157
  • [22] Significance of Glisson's capsule invasion in patients with colorectal liver metastases undergoing resection
    Hiroyoshi, Junko
    Arita, Junichi
    Gonoi, Wataru
    Akamatsu, Nobuhisa
    Kaneko, Junichi
    Hasegawa, Kiyoshi
    AMERICAN JOURNAL OF SURGERY, 2019, 218 (05) : 887 - 893
  • [23] The role of perioperative inflammatory-based prognostic systems in patients with colorectal liver metastases undergoing surgery. A cohort study
    Solaini, Leonardo
    Atmaja, Bambang T.
    Arumugam, Prabhu
    Hutchins, Robert R.
    Abraham, Ajit T.
    Bhattacharya, Satyajit
    Kocher, Hemant M.
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 36 : 8 - 12
  • [24] Effect of high ligation on survival of patients undergoing surgery for primary colorectal cancer and synchronous liver metastases
    Matsui, S.
    Okabayashi, K.
    Hasegawa, H.
    Tsuruta, M.
    Shigeta, K.
    Ishida, T.
    Yamada, T.
    Kondo, T.
    Yamauchi, S.
    Sugihara, K.
    Kitagawa, Y.
    BJS OPEN, 2020, 4 (03): : 508 - 515
  • [25] Surgical and Oncologic Outcomes After Major Liver Surgery and Extended Hemihepatectomy for Colorectal Liver Metastases
    Ubink, Inge
    Jongen, Jennifer M. J.
    Nijkamp, Maarten W.
    Meijer, Eelco F. J.
    Vellinga, Thomas T.
    van Hillegersberg, Richard
    Molenaar, I. Quintus
    Rinkes, Inne H. M. Borel
    Hagendoorn, Jeroen
    CLINICAL COLORECTAL CANCER, 2016, 15 (04) : E193 - E198
  • [26] Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer
    Dagenborg, Vegar Johansen
    Brudvik, Kristoffer Watten
    Lund-Andersen, Christin
    Torgunrud, Annette
    Lund-Iversen, Marius
    Flatmark, Kjersti
    Larsen, Stein Gunnar
    Yaqub, Sheraz
    ANNALS OF SURGERY, 2024, 280 (05) : 745 - 752
  • [27] Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer
    Scherman, P.
    Syk, I.
    Holmberg, E.
    Naredi, P.
    Rizell, M.
    BJS OPEN, 2020, 4 (01): : 118 - 132
  • [28] Liquid Biopsies in Colorectal Liver Metastases: Towards the Era of Precision Oncologic Surgery
    Tsilimigras, Diamantis, I
    Ntanasis-Stathopoulos, Ioannis
    Pawlik, Timothy M.
    CANCERS, 2022, 14 (17)
  • [29] Interdisciplinary Treatment of Patients with Colorectal Liver Metastases
    Schulze-Bergkamen, Henning
    Jaeger, Dirk
    VISZERALMEDIZIN, 2012, 28 (01): : 43 - 49
  • [30] The association of KRAS mutation with primary tumor location and survival in patients undergoing resection of colorectal cancers and synchronous liver metastases
    Allievi, Niccolo
    Goffredo, Paolo
    Utria, Alan F.
    Pisano, Michele
    Poiasina, Elia
    Lucianetti, Alescandro
    Zhou, Paige
    Hassan, Imran
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (05)